These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8729586)

  • 21. Development and pharmacology of fluvastatin.
    Jokubaitis LA
    Br J Clin Pract Suppl; 1994 Dec; (77):11-5. PubMed ID: 19489169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of fluvastatin therapy for hypercholesterolemia after heart transplantation: results of a randomised double blind placebo controlled study.
    O'Rourke B; Barbir M; Mitchell AG; Yacoub MH; Banner NR
    Int J Cardiol; 2004 Apr; 94(2-3):235-40. PubMed ID: 15093987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and tolerability of fluvastatin XL 80 mg alone, ezetimibe alone, and the combination of fluvastatin XL 80 mg with ezetimibe in patients with a history of muscle-related side effects with other statins.
    Stein EA; Ballantyne CM; Windler E; Sirnes PA; Sussekov A; Yigit Z; Seper C; Gimpelewicz CR
    Am J Cardiol; 2008 Feb; 101(4):490-6. PubMed ID: 18312764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of D-003, a mixture of long-chain aliphatic primary acids, fluvastatin and the combined therapy of D-003 plus fluvastatin on the lipid profile of normocholesterolemic rabbits.
    Mendoza S; Gamez R; Mas R; Goicochea E
    Int J Tissue React; 2003; 25(3):81-9. PubMed ID: 14756189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risks associated with statin therapy: a systematic overview of randomized clinical trials.
    Kashani A; Phillips CO; Foody JM; Wang Y; Mangalmurti S; Ko DT; Krumholz HM
    Circulation; 2006 Dec; 114(25):2788-97. PubMed ID: 17159064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No detrimental effect on renal function during long-term use of fluvastatin in renal transplant recipients in the Assessment of Lescol in Renal Transplantation (ALERT) study.
    Fellström B; Abedini S; Holdaas H; Jardine AG; Staffler B; Gimpelewicz C;
    Clin Transplant; 2006; 20(6):732-9. PubMed ID: 17100723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluvastatin reduces the impact of diabetes on long-term outcome after coronary intervention--a Lescol Intervention Prevention Study (LIPS) substudy.
    Arampatzis CA; Goedhart D; Serruys PW; Saia F; Lemos PA; de Feyter P;
    Am Heart J; 2005 Feb; 149(2):329-35. PubMed ID: 15846273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of fluvastatin on the pharmacokinetics and pharmacodynamics of ezetimibe.
    Reyderman L; Kosoglou T; Cutler DL; Maxwell S; Statkevich P
    Curr Med Res Opin; 2005 Aug; 21(8):1171-9. PubMed ID: 16083526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Updated clinical safety experience with fluvastatin.
    Jokubaitis LA
    Am J Cardiol; 1994 May; 73(14):18D-24D. PubMed ID: 8198019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of fluvastatin on hyperlipidemia after renal transplantation.
    Tokumoto T; Tanabe K; Ishida H; Shimmura H; Ishikawa N; Goya N; Akiba T; Toma H
    Transplant Proc; 2004 Sep; 36(7):2141-4. PubMed ID: 15518777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review of side-effect profile of combination ezetimibe and statin therapy in randomized clinical trials.
    Kashani A; Sallam T; Bheemreddy S; Mann DL; Wang Y; Foody JM
    Am J Cardiol; 2008 Jun; 101(11):1606-13. PubMed ID: 18489938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV).
    Dunkelgrun M; Boersma E; Schouten O; Koopman-van Gemert AW; van Poorten F; Bax JJ; Thomson IR; Poldermans D;
    Ann Surg; 2009 Jun; 249(6):921-6. PubMed ID: 19474688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety of statins when response is carefully monitored: a study of 336 heart recipients.
    Marzoa-Rivas R; Crespo-Leiro MG; Paniagua-Marin MJ; Llinares-García D; Muñiz-Garcia J; Aldama-López G; Piñón-Esteban P; Campo-Pérez R; Castro-Beiras A
    Transplant Proc; 2005 Nov; 37(9):4071-3. PubMed ID: 16386629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluvastatin as co-medication in heart transplant recipients with elevated creatine-kinase.
    Sadoni S; Kaczmarek I; Delgado O; Schmöckel M; Reichart B; Meiser B
    Transplant Proc; 2007 Mar; 39(2):558-9. PubMed ID: 17362781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The patient at risk: who should we be treating?
    Shviro I; Leitersdorf E
    Br J Clin Pract Suppl; 1996 Jan; 77A():24-7. PubMed ID: 8729587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuromuscular toxicity in nephrotic patients treated with fluvastatin.
    Gazarin S; Abd-El-Hady H; Gheith O; Rasem M; Saad M; El-Sayed K; Sobh M; Amer G
    J Nephrol; 2002; 15(6):690-5. PubMed ID: 12495286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluvastatin-induced rhabdomyolysis.
    Modi JR; Cratty MS
    Ann Pharmacother; 2002 Dec; 36(12):1870-4. PubMed ID: 12452746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rhabdomyolysis induced by co-administration of fluvastatin and colchicine.
    Sarullo FM; Americo L; Di Franco A; Di Pasquale P
    Monaldi Arch Chest Dis; 2010 Sep; 74(3):147-9. PubMed ID: 21110512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statin toxicity: a situation that mimics viral hepatitis.
    Cokça F; Ozkan S; Nergisoglu G; Memikoglu O; Azap A
    Int J Clin Pharmacol Ther; 2005 Nov; 43(11):543-5. PubMed ID: 16300170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.